Radiology

Exo® Wins 2023 BIG Innovation Award for Exo Works™

Retrieved on: 
Wednesday, January 11, 2023
Health, Medical Devices, Technology, Audio, Video, Software, Radiology, Artificial Intelligence, POCUS, Documentation, Face, Caregiver, PACS, Smartphone, Web browser, Patient, Frustration, Physician, Medical imaging, Medicine, Exo

Exo (pronounced “echo”), a pioneering medical imaging software and devices company, today announced it has been named a winner in the 2023 BIG Innovation Awards , presented by the Business Intelligence Group.

Key Points: 
  • Exo (pronounced “echo”), a pioneering medical imaging software and devices company, today announced it has been named a winner in the 2023 BIG Innovation Awards , presented by the Business Intelligence Group.
  • Exo launched Exo Works in March 2022 to make it easy to address common ultrasound challenges.
  • We designed Exo Works with physicians and patients at the forefront, so that exam documentation is now a breeze,” said Sandeep Akkaraju, CEO and co-founder of Exo.
  • “The entire Exo team is honored to be recognized by the BIG Innovation Awards as we continue our mission to bring medical imaging everywhere.”
    To learn more about Exo Works, click here .

Soleo Health Selected as Sole Specialty Pharmacy Distributor of Newly FDA-Approved LEQEMBI™ (lecanemab-irmb) for Treatment of Alzheimer’s Disease

Retrieved on: 
Tuesday, January 10, 2023
Other Health, Radiology, Other Science, Software, Pharmaceutical, Research, Oncology, Medical Devices, Infectious Diseases, Hospitals, Technology, Fitness & Nutrition, Clinical Trials, Cardiology, Science, Biotechnology, Practice Management, Insurance, Nursing, Managed Care, Medical Supplies, AIDS, General Health, FDA, Health, Diabetes, Professional Services, Practitioner, Caregiver, Health, FDA, AD, TCMC, Hope, Partnership, Patient, Eisai, Food and Drug Administration, MCI, AICS, Medicine, Hospital

Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected by Eisai Inc., a developer of pharmaceuticals, as the sole specialty pharmacy distribution partner for newly U.S. Food & Drug Administration (FDA)-approved LEQEMBI™ (lecanemab-irmb) for the treatment of Alzheimer’s Disease (AD).

Key Points: 
  • Soleo Health , an innovative leader and national provider of complex specialty pharmacy services, announced today it has been selected by Eisai Inc., a developer of pharmaceuticals, as the sole specialty pharmacy distribution partner for newly U.S. Food & Drug Administration (FDA)-approved LEQEMBI™ (lecanemab-irmb) for the treatment of Alzheimer’s Disease (AD).
  • Soleo Health’s distinctive Alzheimer’s Disease TCMC is supported through the Company’s specialty pharmacy locations nationwide with pharmacy licensure in all 50 states.
  • “The selection of Soleo Health as the sole specialty pharmacy distributor for LEQEMBI reflects confidence in our clinical expertise and differentiated patient care model supporting patients in the neurology space.
  • For more information about LEQEMBI therapy and services through Soleo Health, contact the Company’s Alzheimer’s Disease TCMC at 844.960.9090 or via email at [email protected] .

Cerveau Technologies Inc. and Prothena Sign Agreement to Provide Novel Tau Imaging Biomarker for Research and Development of Investigational Therapeutics for Neurodegenerative Diseases

Retrieved on: 
Tuesday, January 10, 2023
Research, Medical Devices, Neurology, Health Technology, Biotechnology, Radiology, Health, Pharmaceutical, Science, PET, Brain, Positron emission tomography, Rapunzel's Tangled Adventure (season 2), Non-fungible token, Acceleration, Therapy, Research, Human, Neurodegeneration, Medical imaging, Pharmaceutical industry

NFTs made up of aggregated tau protein are a hallmark of several neurodegenerative diseases, including Alzheimer’s disease.

Key Points: 
  • NFTs made up of aggregated tau protein are a hallmark of several neurodegenerative diseases, including Alzheimer’s disease.
  • The collaboration is focused on using [F-18]MK-6240 as a biomarker in Prothena’s neurodegenerative disease drug research and development.
  • The companies will apply [F-18]MK-6240 imaging to evaluate Prothena’s investigational therapeutics for potential treatment of neurodegenerative diseases in humans, with a focus on Alzheimer’s Disease.
  • Our goal is to expand the availability of this novel investigational imaging agent to the broader scientific community.”

GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook

Retrieved on: 
Tuesday, January 10, 2023
Data Management, Medical Supplies, Technology, Professional Services, Health, Radiology, Pharmaceutical, Health Technology, Medical Devices, Data Analytics, Hospitals, PP, Organic, Tax, PP&E, Total, GE, Health, Adjustment, Outlook, Conference, Growth, Spin-off, EBIT, Interest, Acquisition, GE Healthcare, General Electric Company, Pharmaceutical industry, Renewable energy, Video game, Bank, Real estate

GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full year 2022.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, today announced preliminary unaudited revenue results for the fourth quarter and full year 2022.
  • Mr. Arduini said, “We delivered strong year-over-year revenue growth in the fourth quarter and full year, reflecting robust customer demand, backlog fulfillment, and improved pricing.
  • We are also pleased to provide our financial outlook for 2023, reflecting continued growth as we execute on our strategic plan.
  • GE HealthCare will report fourth quarter and full year 2022 results on January 30, 2023, followed by a conference call at 8:00 am ET.

ATCC Announces Participation with Areté on IARPA Contract to Develop New Methods for Identifying Low-Dose Radiation Exposure

Retrieved on: 
Tuesday, January 10, 2023
Oncology, Health, Genetics, Radiology, Research, Science, Biotechnology, ODNI, Intelligence, Perspiration, Doctor of Philosophy, Government, Safety, Machine learning, Skin, Senior, Health, Intelligence Advanced Research Projects Activity, IARPA, Artificial intelligence, Saliva, Radiation, Research, TEI, Science, United States Intelligence Community, Human, Hair, Medical imaging, ATCC

According to IARPA , it is pursuing new technologies to identify low-dose radiation exposure, determine the exposure timeline and pinpoint environmental factors related to the place of exposure.

Key Points: 
  • According to IARPA , it is pursuing new technologies to identify low-dose radiation exposure, determine the exposure timeline and pinpoint environmental factors related to the place of exposure.
  • The TEI-REX program research goals are to protect better the health and safety of the intelligence community and military and government personnel overseas while supporting nuclear counterproliferation efforts.
  • New assays using biological markers may result in more robust, accurate, and quicker ways to detect the effects of ionizing radiation on humans.
  • “ATCC is pleased to be on the team with Areté in developing a novel, non-invasive assay for detecting low-level ionizing radiation,” said Dr. Joseph Leonelli, Senior Vice President, ATCC Federal Solutions.

University of South Florida Health, Northwell Health, Tampa General Hospital and Formlabs earn national recognition for 3D-printed nasal swab used in pandemic

Retrieved on: 
Thursday, January 12, 2023
Patents for Humanity, PARK, Hospital, COVID-19 testing, University, Medical/Market Center station, Temperature, Internal medicine, Regeneron Pharmaceuticals, Patent, COVID-19, University of Texas Health Science Center Department of Radiology, Pressure, Tampa General Hospital, Health, Gilead Sciences, 3D, Humanity, National Institute of Allergy and Infectious Diseases, Formlabs, Patient, University of South Florida, Thomas Jefferson University Hospital, Clinical trial, NP, USF Health Byrd Alzheimer's Institute, Infection, Northwell Health, Innovation, USF, Doctor of Philosophy, NIH, 3D printing, Pharmaceutical industry, Medicine, Management, MD, Radiology

TAMPA, Fla. SOMERVILLE, Mass. and NEW HYDE PARK, N.Y., Jan. 12, 2023 /PRNewswire/ -- The University of South Florida (USF) has been awarded the Patents for Humanity award by the U.S. Patent and Trademark Office (USPTO) for its patent of the 3D-printed nasopharyngeal (NP) swab, created in the early part of the pandemic as a solution to the disrupted commercial production of standard flocked NP swabs critical in diagnostic testing for COVID-19.

Key Points: 
  • All will be honored by the USPTO at an awards ceremony on February 16, 2023.
  • USF is earning this recognition for its innovative solution to the commercial NP swab shortage.
  • From that point on , the USF/Northwell design was shared with hospitals, health systems, the military, and clinics around the globe.
  • Formlabs is proud to be recognized alongside USF Health, Northwell Health, and Tampa General Hospital in the USPTO Patents for Humanity COVID-19 category."

Ferrum Health Raises $6 Million to Bring Artificial Intelligence into Healthcare

Retrieved on: 
Thursday, January 12, 2023
Catalog, Algorithm, Approximation error, Ferrum, Singtel, Machine learning, AI, Diagnosis, Radiology, Growth, Health, Patient, SAN, Traction, Sutter Health, Tran, Medical device

SAN FRANCISCO, Jan. 12, 2023 /PRNewswire/ -- Ferrum Health , a healthcare artificial intelligence (AI) platform developer, announced that it has recently raised $6 million in a funding round led by Urban Innovation Fund , Cercano Management , and Singtel Innov8 .

Key Points: 
  • SAN FRANCISCO, Jan. 12, 2023 /PRNewswire/ -- Ferrum Health , a healthcare artificial intelligence (AI) platform developer, announced that it has recently raised $6 million in a funding round led by Urban Innovation Fund , Cercano Management , and Singtel Innov8 .
  • "We are excited to have the support of Urban Innovation Fund, Singtel Innov8, and Cercano Management in our mission to bring AI to healthcare," said Pelu Tran, CEO of Ferrum Health.
  • Ferrum has already seen significant traction for its Enterprise AI Platform, with major healthcare organizations such as Sutter Health and Carle Clinic adopting its technology.
  • Julie Lein, Managing Partner of Urban Innovation Fund, added: "Ferrum Health is building the 'Plaid for AI' in healthcare data.

Henry Community Health, in Indiana, US, chooses DR 800: a multifunctional room that performs a full range of radiography and fluoroscopy exams, with one investment

Retrieved on: 
Thursday, January 12, 2023
DSA, Fluoroscopy, Radiology, Channel, Agfa-Gevaert, Radiography, Workflow, Medical imaging, Hospital

MORTSEL, Belgium, Jan. 12, 2023 /PRNewswire/ -- 

Key Points: 
  • The hospital has chosen to install Agfa's multifunctional DR 800, which adds clinical value to a wide range of applications, with a single room and a single investment.
  • The versatile DR 800 delivers a smooth and efficient workflow for a full range of radiography and fluoroscopy exams.
  • The DR 800 is the ideal solution, as it can handle different types of exams, including both radiography and fluoroscopy.
  • The versatile DR 800 can handle a full range of radiography and fluoroscopy exams with a single investment and no need for additional specialty rooms.

Glassbeam Appoints Rich Jones as CEO to Accelerate Adoption of Glassbeam's Predictive Analytics for Intelligent Hospitals

Retrieved on: 
Thursday, January 12, 2023
Hospital, Entrepreneurship, The Advisory Board Company, Face, Machine learning, Google Images, Organization, Marketing, Radiology, Growth, Intelligence, Software as a service, Health, Management, Medicine

Mr. Jones joins Glassbeam having formerly served as President of Radiology at Akumin, Inc., a comprehensive provider of diagnostic imaging and oncology solutions.

Key Points: 
  • Mr. Jones joins Glassbeam having formerly served as President of Radiology at Akumin, Inc., a comprehensive provider of diagnostic imaging and oncology solutions.
  • Mr. Jones also served on the Board of Directors for the Association for Quality Imaging during his tenure as President of Radiology at Alliance.
  • "On behalf of the Board, I am thrilled to welcome Rich Jones to our team," said Eric Milledge, Chairman of the Board at Glassbeam.
  • Under Mr. Pandit's leadership, Glassbeam became a leader in data and predictive analytics for connected medical machines.

IDX Selects Medality to Help Radiologists Learn at Work

Retrieved on: 
Thursday, January 12, 2023
Accreditation, Accreditation Council, ACCME, Learning, American Board of Commissioners for Foreign Missions, RIS, American Board of Radiology, Accreditation Council for Continuing Medical Education, Partnership, IDX, AMA, SCCT, Faculty of Medical Leadership and Management, Kaisar-i-Hind Medal, Continuing medical education, MOC, Medical imaging, Radiology

CINCINNATI, Jan. 12, 2023 /PRNewswire-PRWeb/ -- Today, Integral Diagnostics (IDX), a leading provider of medical imaging services across Australia and New Zealand, announced that it has selected Medality as its radiology training and development partner of choice. IDX will integrate Medality's practice development solutions into its RIS/PACS workflow for IDX radiologists across its 72 clinics.

Key Points: 
  • IDX will integrate Medality's practice development solutions into its RIS/PACS workflow for IDX radiologists across its 72 clinics.
  • As a leading employer of radiologists in the region, IDX knows that well-trained, well-equipped and happy radiologists make the best clinicians.
  • Medality is now being rolled out to more than 90 radiologists across 72 IDX clinics throughout Australia and New Zealand.
  • "Our mission is to transform the way radiologists learn and thrive," shared Daniel Arnold, the CEO and Co-Founder of Medality.